Cita APA (7a ed.)
Frieling, K., Monte, S. V., Jacobs, D., & Albanese, N. P. (2021). Weight loss differences seen between glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors for treatment of type 2 diabetes. Journal of the American Pharmacists Association: JAPhA, 61(6), 772-778.
Cita Chicago Style (17a ed.)
Frieling, Katherine, Scott V. Monte, David Jacobs, y Nicole Paolini Albanese. "Weight Loss Differences Seen Between Glucagon-like Peptide-1 Receptor Agonists and Sodium-glucose Cotransporter-2 Inhibitors for Treatment of Type 2 Diabetes." Journal of the American Pharmacists Association: JAPhA 61, no. 6 (2021): 772-778.
Cita MLA (9a ed.)
Frieling, Katherine, et al. "Weight Loss Differences Seen Between Glucagon-like Peptide-1 Receptor Agonists and Sodium-glucose Cotransporter-2 Inhibitors for Treatment of Type 2 Diabetes." Journal of the American Pharmacists Association: JAPhA, vol. 61, no. 6, 2021, pp. 772-778.
Precaución: Estas citas no son 100% exactas.